NPR’s Juana Summers talks with WeightWatchers CEO Sima Sistani concerning the firm’s current determination to supply weight reduction medication like Wegovy and Ozempic.
JUANA SUMMERS, HOST:
The web lit up earlier this week when Oprah Winfrey advised Individuals journal that she’s been utilizing a weight reduction drug to lose and preserve her weight. The media powerhouse stated the drug has been a aid, a redemption and a present. Quote, “I am completely finished with the shaming from different individuals and significantly myself.” Winfrey is giving voice to what numerous individuals have felt since embracing a category of medication that had been initially authorised for diabetes however at the moment are being extensively embraced for weight reduction. WeightWatchers, the decades-old weight reduction and weight administration program, can also be embracing these new medication, that are generally known as GLP-1s. It’s a huge shift for an organization that has spent 60 years advising individuals to rely their energy or their factors and use willpower. Sima Sistani is the CEO of WeightWatchers, and he or she joins me now. Welcome.
SIMA SISTANI: Thanks for having me, Juana.
SUMMERS: This has been extremely huge information for individuals who have or are combating their weight and who’ve regarded to Oprah Winfrey as a supply of inspiration. I imply, Oprah’s fluctuating weight in her physique and the remedy she’s obtained due to it has been a subject of public dialogue for so long as I can bear in mind. And Oprah can also be the form of one who clearly doesn’t endure from a scarcity of grit and resilience and dedication. I wish to begin by asking you, what instance does her newest revelation that she is utilizing these class of medicines give people who find themselves combating weight reduction on their very own?
SISTANI: Look. I believe it is actually essential that we acknowledge that there was a decadeslong narrative that has painted weight reduction as a mere take a look at of willpower. And it is perpetuated this sense of disgrace and misunderstanding round what it means to stay with obese and weight problems. So for some, totally different options like these new scientific interventions are actually wanted.
SUMMERS: On the similar time, I imply, listening to Oprah speak concerning the liberation that she feels, the flexibility to higher handle her weight, to take a dose of one in all these medication earlier than Thanksgiving, when, , like many people, she’s going to have an enormous dinner – it is a highly effective message, however she can also be somebody who’s invested in your organization. Do you assume that dilutes the facility of the message that she’s giving to people who find themselves going through comparable struggles?
SISTANI: Effectively, look. Ms. Winfrey, together with the remainder of our board, stands by our enterprise imaginative and prescient and our program choices. However everyone knows that her story has been one which has been a generational story and one which mimics so many individuals who, on a day-to-day foundation, battle with the identical disgrace and bias, the place weight reduction has been related to a preoccupation round thinness. And what we’re attempting to do is reshape that dialog round weight well being. It isn’t a matter of vainness. That is concerning the diploma to which weight impacts your well being and your high quality of life. And for many years, we have mentioned weight and weight-reduction plan and weight problems in phrases that isolate individuals and infrequently demotivate them.
SUMMERS: So does that imply that the recommendation that WeightWatchers gave individuals, together with myself, I ought to be aware – I am a type of individuals who turned to WeightWatchers at numerous factors in my very own journey combating my very own weight – was the recommendation that we got for years about what it takes to drop a few pounds, that concentrate on dedication and resilience and willpower – was that recommendation simply mistaken?
SISTANI: I’ll say, as someone who was very humbled to take this function as a result of WeightWatchers additionally labored for me, sure, that recommendation was mistaken as a result of we stated it was selection, not probability. And the reality is that this can be a continual situation. And finally, for each one person who we helped, that there was one one who our program didn’t work for as a result of they had been coping with a continual, relapsing situation with biology and genetics and environmental underpinnings. And so to ensure that us to reintroduce ourselves, we have to acknowledge the half that we had prior to now.
SUMMERS: There are some actual questions on the market about how a lot we do not know proper now concerning the long-term results of medicines like Ozempic and Wegovy, examples of the GLP-1s that we have been discussing. How does this program reply and converse to a few of these issues?
SISTANI: Effectively, GLP-1s usually are not new. The indication for weight problems is new, however they’ve been prescribed for many years for individuals dwelling with diabetes. In order that gave us a whole lot of consolation in embracing this scientific pathway.
SUMMERS: I do wish to handle the query of entry and price right here. Many individuals cannot afford to take these medication. Individuals speak about spending tons of, if no more than $1,000, to entry pharmaceuticals like Wegovy and Ozempic if they are not lined by insurance coverage. And I’d think about, then, that there are extra who cannot afford to take these medicines indefinitely. Do you are concerned in any respect that this units people who find themselves longing for options and desirous to drop a few pounds up for long-term frustration?
SISTANI: Effectively, I believe you are mentioning a extremely essential cultural dialog, which is these medicines proper now are extremely costly, and they need to be lined. It’s prison, in my view, that they don’t seem to be lined. And they’re put in the identical class proper now as, , medicines for hair loss, and erectile dysfunction. It is a reflection of our healthcare system being based mostly on a illness mannequin versus fascinated about preventative measures for weight well being. And so we’re having that dialog at a coverage degree, as properly, in order that we will ensure that everybody can have entry to assist and care that they want.
SUMMERS: One thing I take into consideration rather a lot that I would like to get your tackle is whether or not you are concerned about individuals on the market who may see medicines as a fast repair for one thing that may be so complicated and so particular person.
SISTANI: There are not any fast fixes. Even these medicines – finally, they do not substitute life-style intervention. And I believe the main focus that we wish is to acknowledge the continual situation in order that we will change the bias within the dialog for what’s finally a really lonely expertise for a lot of.
SUMMERS: I would prefer to ask you a query from one in all our editors on the present, if I can. She is somebody who has used WeightWatchers efficiently at occasions, much less efficiently at others, to try to preserve a wholesome weight and to be ok with herself. And one factor she advised me that she has seen in WeightWatchers social communities for the reason that announcement that you just all had been going to begin providing and permitting people to have entry and serving to them get entry to those medicines is that amongst some individuals, there’s this sense of betrayal on the firm’s embrace of those medication. What do you say to these clients?
SISTANI: So I perceive that. You realize, change is tough. And we have, , all been part of the tradition and and that narrative. However what I’ve shared to our staff and to our members is that what makes WeightWatchers distinctive is that so many people select to be right here as a result of we consider within the mission and we consider within the energy of community-driven well being. And in order that has to come back with an unwavering dedication to radical candor.
SUMMERS: That was WeightWatchers CEO Sima Sistani. Thanks a lot for being right here.
SISTANI: Thanks.
Copyright © 2023 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional info.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content might not be in its closing kind and could also be up to date or revised sooner or later. Accuracy and availability could differ. The authoritative file of NPR’s programming is the audio file.
